Item 7.01 Regulation FD Disclosure. On October 28, 2026, Beneficient (the “Company”) issued a press release announcing that the Company and certain of its subsidiaries filed a motion to intervene in the Delaware Court of Chancery litigation previously brought by HCLP Nominees, L.L.C. (“HCLP”) against Delaware Trust Company (“DTC”).…
Filed Oct 28, 2026Accepted Oct 28, 2026, 7:45 AM EDTCIK 1775734Accession 0001493152-26-048820
We are a technology-enabled financial services company that provides simple, rapid, and cost-effective liquidity solutions and related trustee, custody and trust administrative services to participants in the alternative asset industry. Through our business line operating subsidiaries (each a “Ben Business Unit” and collectively, the “Ben Business Units”), Ben Liquidity, Ben Custody, and Ben Markets (each as defined below), we seek to provide solutions in the alternative asset investment market for individual and institutional investors, general partners and sponsors (“GPs”) and the alternative asset funds they manage (“Customers”). Following receipt of regulatory approval, our Ben Business Units are expected to include an additional business line, Ben Insurance Services. Our products and services are designed to meet the unmet needs of mid-to-high net worth (“MHNW”) individual investors, small-to-midsize institutional (“STMI”) investors, family offices (“FAMOs”) and GPs, which collectively are our Customers.
Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 7.01Item 7.01 - Regulation FD Disclosure
Item
7.01 Regulation FD Disclosure.
On
October 28, 2026, Beneficient (the “Company”) issued a press release announcing that the Company and certain of its
subsidiaries filed a motion to intervene in the Delaware Court of Chancery litigation previously brought by HCLP Nominees, L.L.C. (“HCLP”)
against Delaware Trust Company (“DTC”).
A
copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein.
The
information in this Item 7.01 (including Exhibit 99.1) is being furnished pursuant to Item 7.01 and shall not be deemed to be “filed”
for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise
subject to liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933,
as amended (the “Securities Act”), except as expressly set forth in such filing.
Item 8.01Item 8.01 - Other Events
Item
8.01 Other Events.
As
previously announced, the Company has formulated and is implementing a comprehensive strategy intended to eliminate both the fraudulent
indebtedness asserted by HCLP and the equity interests in the Company and its subsidiaries held by the Company’s former Chief Executive
Officer, Brad Heppner, and his affiliated entities. The Company’s motion to intervene in litigation previously brought by
HCLP against DTC furthers this strategy and seeks to invalidate the HCLP credit agreements and related loan documents and cancel
the purported obligations, recover the approximately $211 million the Company previously paid on the purported debt and establish that
HCLP has no valid right to the related collateral.
Forward-Looking Statements
Some of the statements contained in
this Current Report on Form 8-K are forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E
of the Exchange Act. These forward-looking statements reflect our views with respect to future events as of the date of this document
and are based on our management’s current expectations, estimates, forecasts, projections, assumptions, beliefs and information.
Although management believes that the expectations reflected in these forward-looking statements are reasonable, it can give no assurance
that these expectations will prove to have been correct. All such forward-looking statements are subject to risks and uncertainties,
many of which are outside of our control, and could cause future events or results to be materially different from those stated or implied
in this document. It is not possible to predict or identify all such risks. Many factors could cause actual future events to differ materially
from the forward-looking statements in this Current Report on Form 8-K, including but not limited to: the risk that the outcome and timing
of the HCLP litigation, negotiations and other proceedings involving Mr. Heppner, HCLP and related parties may not be favorable; the
risk that we may not be able to negotiate a consensual resolution with Mr. Heppner on terms that are favorable, or at all; the ability
to enter into a definitive agreement with respect to a proposed resolution; the outcome of any appeal or other proceeding relating to
Mr. Heppner’s conviction; the risk that the Company is unable to obtain the relief it seeks or otherwise implement its strategy;
disputes concerning the validity, enforceability, ownership, amount, value or conversion of the HCLP claims or other Heppner-related
interests; the need for third-party or governmental actions, consents or approvals; the accounting and tax treatment of any resolution;
risks related to the substantial costs and diversion of management’s attention and resources due to these matters; and the risk
factors that are described under the section titled “Risk Factors” in our Annual Report on Form 10-K, Quarterly Reports on
Form 10-Q, Current Reports on Form 8-K, and other filings with the Securities and Exchange Commission (the “SEC”). These
factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included
in this document and in our SEC filings. We expressly disclaim any obligation to publicly update or review any forward-looking statements,
whether as a result of new information, future developments or otherwise, except as required by applicable law.
Filed exhibits (1)
EX-99.1 (by filename) ex99-1.htm
Exhibit
99.1
Beneficient
Advances Strategy to Eliminate HCLP Debt and Heppner Interests
Company
seeks to invalidate purported HCLP debt
DALLAS,
October 28, 2026 (GLOBE NEWSWIRE) - Beneficient (NASDAQ: BENF) (“Beneficient” or the “Company”), which
provides liquidity and primary capital solutions and related fiduciary services for alternative assets, today announced that it has taken
a significant step in executing its previously announced strategy to eliminate the purported HCLP debt and achieve a complete separation
from former Chief Executive Officer Brad Heppner and his affiliated entities.
On
October 23, 2026, the Company and certain subsidiaries filed a motion to intervene in the Delaware Court of Chancery litigation previously
brought by HCLP Nominees, L.L.C. (“HCLP”) against Delaware Trust Company. The accompanying proposed verified complaint seeks
to invalidate the HCLP credit agreements and related loan documents and cancel the purported obligations based on their role in Heppner’s
scheme, recover the approximately $211 million the Company previously paid on the purported debt, and establish that HCLP has no valid
right to the related collateral. If successful, this act…